Similar articles

• The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction.

  Young FE, Nightingale SL, Temple RA. Young FE, et al. JAMA. 1988 Jun 3;259(21):3158-60. JAMA. 1988. PMID: 3367492 No abstract available.
• An overview of the British and American aspirin studies.

  Hennekens CH, Peto R, Hutchison GB, Doll R. Hennekens CH, et al. N Engl J Med. 1988 Apr 7;318(14):923-4. doi: 10.1056/NEJM198804073181412. N Engl J Med. 1988. PMID: 3352678 No abstract available.
• Regulating information about aspirin and the prevention of heart attack.

  Keith A. Keith A. Am Econ Rev. 1995 May;85(2):96-9. Am Econ Rev. 1995. PMID: 10160518 No abstract available.
• The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States.

  Hennekens CH, Jonas MA, Buring JE. Hennekens CH, et al. Arch Intern Med. 1994 Jan 10;154(1):37-9. Arch Intern Med. 1994. PMID: 8267487 Review.
• Prophylactic aspirin and the elderly population.

  Dalen JE, Goldberg RJ. Dalen JE, et al. Clin Geriatr Med. 1992 Feb;8(1):119-26. Clin Geriatr Med. 1992. PMID: 1576570 Review.